Improving Functional Recovery After Hip Fracture
Launched by NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES (NIAMS) · Jan 29, 2000
Trial Information
Current as of March 21, 2025
Completed
Keywords
ClinConnect Summary
The specific aims of this project are to (a) implement an intervention program of patient education focused on self-efficacy (the belief that one's actions are responsible for successful outcomes) and strength training designed to improve the postoperative rehabilitation of older persons (65 years of age and older) who have sustained a fracture of the hip; and (b) evaluate in a randomized trial the efficacy of this intervention program to improve the overall postoperative functional status of such patients and decrease the rate of their subsequent institutionalization.
The study will also ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who are 65 years of age and older, and who have been admitted for a hip fracture to the Fracture Service at New York Presbyterian Hospital.
- Exclusion Criteria:
- • Patients who are unable to give informed consent on the 4th or 5th day after surgery.
- • Patients whose hip fracture is due to underlying disease, secondary to malignancy (cancer).
- • Patients who do not speak English.
- • Patients for whom exercise is contraindicated or whose physicians believe that exercise is contraindicated.
- • Patients who do not have access to a telephone or cannot be reached by telephone.
- • Patients and physicians who refuse to participate or who intend to relocate upon discharge.
Trial Officials
John P. Allegrante, PhD
Principal Investigator
Hospital for Special Surgery, New York
About National Institute Of Arthritis And Musculoskeletal And Skin Diseases (Niams)
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is a pivotal component of the National Institutes of Health (NIH) dedicated to advancing research and knowledge in the fields of arthritis, musculoskeletal disorders, and skin diseases. NIAMS sponsors a wide range of clinical trials aimed at improving the diagnosis, treatment, and prevention of these conditions. By fostering innovative research, collaborating with healthcare professionals, and engaging with patient communities, NIAMS strives to enhance the quality of life for individuals affected by these diseases, while promoting scientific discovery and public health initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials